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Background: Activation of the Wnt pathway is known to promote tumorigenesis and tumor metastasis, and
targeting Wnt pathway inhibition has emerged as an attractive approach for controlling tumor invasion and
metastasis. The major pathway for inhibiting Wnt is through the degradation of β-catenin by the GSK3-beta/CK1/
Axin/APC complex. It was found that Hep3B hepato-carcinoma cells respond to anthocyanins through GSK3-beta-
induced suppression of beta-catenin; however, they cannot dephosphorylate GSK3-beta without AMPK activation.
Methods: We tested the effects of anthocyanins on proliferation and apoptosis by MTT and Annexin V-PI staining
in vitro. Mouse xenograft models of hepato-carcinomas were established by inoculation with Hep3B cells, and mice
were injected with 50 mg/kg/ml of anthocyanins. In addition, protein levels of p-GSK3-beta, beta-catenin, p-AMPK,
MMP-9, VEGF, and Ang-1 were also analyzed using western blot.
Results: Anthocyanins decrease phospho-GSK3-beta and beta-catenin expression in an in vivo tumor xenograft
model, increase AMPK activity in this model, and inhibit cell migration and invasion, possibly by inhibiting MMP-2
(in vitro) and the panendothelial marker, CD31 (in vivo). To elucidate the role of the GSK3-beta/beta-catenin pathway
in cancer control, we conditionally inactivated this pathway, using activated AMPK for inhibition. Further, we
showed that AMPK siRNA treatment abrogated the ability of anthocyanins to control cell proliferation and
metastatic potential, and Compound C, an AMPK inhibitor, could not restore GSK3-beta regulation, as exhibited by
anthocyanins in Hep3B cells.
Conclusion: These observations imply that the AMPK-mediated GSK3-beta/beta-catenin circuit plays crucial roles in
inhibiting cancer cell proliferation and metastasis in anthocyanin-treated hepato-carcinoma cells of Meoru origin.
Keywords: AMP-activated protein kinase, Glycogen synthase kinase 3-beta, beta-catenin, Meoru origin anthocyanins,
Anti-metastatic potentialBackground
Hepato-carcinoma is one of the most common cancers
worldwide, and the incidence of new cases has increased in
recent years. It is often highly metastatic and resistant to
anticancer treatment strategies. One of the key genetic
defects that confer resistance against hepato-carcinoma* Correspondence: kym@hnu.kr
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reproduction in any medium, provided the ortreatment is the mutation of β-catenin, which is a key com-
ponent of the Wnt signaling pathway [1]. The Wnt path-
way is crucial to cell proliferation, differentiation, and
survival, and cells with enhanced activation of the Wnt
pathway have strong invasive activity [2]. Invasion of can-
cer cells into surrounding tissue and the vasculature is an
initial step in tumor metastasis [3]. Several studies have
suggested that over-activation of β-catenin in the cyto-
sol is related to cancer metastasis [4]. Under normal
conditions, β-catenin is phosphorylated at Ser33/37 by
active glycogen synthase kinase 3β (GSK3β), triggering. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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active form of GSK3β is in the dephosphorylated state;
however, when it is phosphorylated, GSK3β loses its ac-
tivity and no longer controls β-catenin [6]. Uncontrolled
β-catenin is translocated from the cytosol to nucleus,
where it activates target genes involved in cell prolifera-
tion and metastasis [7]. Recent studies have shown that
several phytochemicals, including anthocyanins, can
regulate cell growth by regulating the phosphorylation
of GSK3β [8]. Anthocyanins from the fruit of Vitis
coignetiae Pulliat (known as meoru in Korea) are water-
soluble flavonoids found in red and blue colored fruits
and vegetables, such as blueberry, cranberry, and red cab-
bage [9,10]. Anthocyanins have been linked to a number
of intracellular functions, including cellular redox status
modification, free radical scavenging activity, and chelation




3-glucoside: peonidin-3-glucoside: malvidin-3-glucoside =
27:63:8.27:1:2.21:2.21:6.7:1.25:5.72:1.25) isolated from V.
coignetiae Pulliat fruits show anti-invasive effects and
apoptotic effects in human hepato-carcinoma cells [12,13].
They also exhibit cancer-preventive effects that occur
through their abilities to interfere with the cell signaling
pathway [8]. Previous experiments have shown that antho-
cyanins induce cell cycle blockage at G1/G0 and G2/M
phases and regulate the extracellular regulated kinase
(ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen-
activated protein kinase (MAPK) pathways in several can-
cer types [14-16]. In addition, anthocyanins have been
shown to inhibit the activation of transcription factors
such as nuclear factor-κB (NF-κB) and activator protein-1
(AP1) [17].
In this study, we analyzed downstream signals of AMPK
to search for naturally originating novel modulators of the
AMPK/GSK3β/β-catenin pathway to control cancer cell
proliferation and metastasis. We found that anthocyanins
activated GSK3β, thereby decreasing β-catenin, and that
AMPK was an upstream regulator of GSK3β/β-catenin
pathway. This information holds promise for therapeutic
modulation of GSK3β/β-catenin-pathway-dependent inva-
siveness in cancer cells.
Methods
Cell culture and reagents
The Hep3B hepato-carcinoma cell line was purchased from
the American Type Culture Collection (Manassas, VA) and
was cultured in Dulbecco’s modified Eagle’s medium with
10% fetal bovine serum (Gibco, Grand Island, NY). Insulin-
like growth factor (IGF)-1, 3-(4,5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) and Hoechst 33342
were obtained from Sigma (St Louis, MO). Compound Cand 6-bromoindirubin-3′-oxime (BIO) were purchased
from Calbiochem (San Diego, CA). Monoclonal antibodies
specific for p-AMPK (Thr172), AMPKα1, p-GSK3β (Ser9),
GSK3β, β-catenin, Ang-1, VEGF and MMP-9 were
purchased from Cell signaling Technology (Beverly,
MA, USA). CD31 antibody was purchased from Abcam
(Cambridge, UK), and β-actin antibody was obtained
from Sigma (St Louis, MO).
Isolation of anthocyanins from Meoru
Anthocyanins were conducted by Won Sup Lee’s group
at Gyeongsang National University School of Medicine.
The plant with voucher specimen number KNKA200
506031111 was deposited in the Korea national arbor-
etum. Fruit of Meoru was collected in the middle of
September 2007 at Jiri mountain in Korea, freeze-dried
and stored in dark glass containers at −20°C until required
for analysis. Anthocyanins pigments were extracted by
maceration of the fruits (100 g) in methanol containing
0.1% HCl at 5°C for 24 h. The extraction procedure was
repeated three times. After concentration under reduced
pressure (Rotavapor R-124, Buchi, Switzerland), the ex-
tract was diluted with distilled water (100 ml) and parti-
tioned against ethyl acetate (100 ml). The water layer
containing the pigments was concentrated to 50 ml. The
concentrate was purified according to established proce-
dures by means of ethyl acetate/water partitioning and ad-
sorption chromatography on a bed of Amberlite XAD-7
(Sigma, Yongin, South Korea) [18].
Cell proliferation measurements
Hep3B cells seeded on 96-well microplates at 4 × 103
cells per well were incubated with the anthocyanins at
the indicated concentrations for 48 h. Following incuba-
tion with the anthocyanins, the medium was removed,
and the cells were then incubated with 100 μl MTT
solution (2 mg/ml MTT in phosphate-buffered saline
(PBS)) for 4 h. The samples were then solubilized in di-
methyl sulfoxide and the purple formazan dye, converted
from MTT by viable cells, was quantified by absorbance
at 560 nm.
Apoptosis detection
Apoptosis was measured using an FITC-Annexin V apop-
tosis detection kit (BD Pharmingen™, San Diego, CA) or
Hoechst 33342 chromatin staining dye. For Annexin V/
propidium iodide staining after treatment with anthocya-
nins, cells were harvested by trypsinization, washed with
ice-cold PBS and suspended in a binding buffer at a dens-
ity of 1 × 106 cells/ml. Cells were stained with Annexin
V-fluorescein isothiocyanate and propidium iodide and
analyzed by flow cytometry (Becton-Dickinson Biosci-
ences, Drive Franklin Lakes, NJ). To examine chromatin
condensation, cells were stained with 10 μM Hoechst
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15 min. Changes in chromatin condensation were ob-
served by fluorescence microscopy (Olympus Optical Co.,
Tokyo, Japan).Wound healing assay
Hep3B cells were grown on 6-well plate to 100% confluent
monolayer and then scratched to form a 100 μm wound
by using sterile pipette tips. The cells were then cultured
in the presence or absence of AIMs (400 μg/ml) in serum-
free media for 24 h. The images were recorded at 0 h and
48 h after scratch using an Olympus photomicroscope
(Olympus Optical Co., Tokyo, Japan).Invasion assay
For the cell invasion assays, Hep3B cells were cultured
in serum-free media overnight. Cells (5 × 104 cells) were
loaded onto pre-coated Matrigel 24-well invasion cham-
bers (BD Biosciences, San Jose, CA) in the presence or
absence of anthocyanins. Then 0.5 ml of medium con-
taining 20% FBS was added to the wells of the plate to
serve as a chemoattractant. The Matrigel invasion cham-
bers were incubated for 24 h. Invading cells were fixed
with 10% formalin, stained with crystal violet, and ana-
lyzed according to manufacturer’s instructions.Gelatin zymography
The gelatinolytic activities of matrix metalloproteinase
(MMP)-2 in the conditioning culture medium were
assayed by electrophoresis on 8% polyacrylamide gels
containing 0.1% gelatin at 4°C. Polyacrylamide gels were
run at 120 V, washed in 2.5% Triton X-100 for 1 h, and
then incubated for 16 h at 37°C in activation buffer
(50 mM Tris–HCl, pH 7.5, 10 mM CaCl2). After stain-
ing with Coomassie blue (10% glacial acetic acid, 30%
methanol and 0.5% Coomassie brilliant blue) for 2 h, the
gel was washed with a solution of 10% glacial acetic acid
and 40% methanol without Coomassie blue for 1 h.
White lysis zones indicating gelatin degradation were
revealed by staining with Coomassie brilliant blue.Western blot
After starvation for 12 h in serum-free medium, cells
were seeded into six-well plates and treated with test
compounds. Total proteins were extracted using a RIPA
lysis buffer (50 mM Tris–HCl (pH 8.0), 1% NP-40, 0.5%
sodium deoxycholate, 150 mM NaCl and 1 mM phenyl-
methylsulfonyl fluoride) and subjected to western blot
analysis with specific antibodies. The proteins were then
visualized by enhanced chemiluminescence (Intron,
Kyunggi, Korea) and detected using an LAS4000 chemi-
luminescence detection system (Fuji, Tokyo, Japan).Transient transfection with small interfering RNA
Specific small interfering RNAs (siRNAs)-targeting AMP
Kα1 (PRKAA1) and mTOR and non-specific control siR-
NAs were purchased from Dharmacon (Chicago, IL). For
transient transfection, cells were seeded at a density of 5 ×
104 cells/ml in antibiotic-free medium, and siRNAs were
transfected using the DharmaFECT4 transfection reagent
(Dharmacon) according to the manufacturer’s instruc-
tions. After incubation for 72 h, the cells were analyzed by
MTTassay or western blot.Tumor formation
Five-week-old male Balb/c nu/nu mice were obtained
from SLC (Tokyo, Japan) and housed in sterile filter-
topped cages. Hep3B hepato-carcinoma cells (1 × 106
cells/150 μl) were subcutaneously injected into the left
flank of the mice. One week after the injection of Hep3B
cells, anthocyanins were dissolved in PBS and adminis-
tered intraperitoneally (50 mg/kg/day) for 20 days. The
control animals were injected with vehicle (PBS) alone.
Tumor size was measured using a caliper at 2 day inter-
vals, and the volume was calculated by the modified
formula V = 1/2 (length × width2). After the 20 day treat-
ment, tumors were removed and frozen in liquid nitro-
gen for western blot analysis or fixed with formalin for
immunohistochemistry. All animal experiments were
approved by the Ethics Committee for Animal Experi-
mentation, Hannam University.Immunohistochemistry
Tumor specimens from mice were fixed in 10% formalde-
hyde, embedded in paraffin and sectioned into 5 μm thick
slices. Sections were deparaffinized with xylene and dehy-
drated with 98% ethanol. Serial sections were stained
using standard immunoperoxidase techniques with pri-
mary antibodies against CD31 (1:100) and p-AMPKα1
(1:50). For epitope retrieval, specimens were microwave
treated for 25 min before incubation with primary anti-
bodies. Pre-immune serum was used as a negative control
for immunostaining, and positive staining was visualized
with diaminobenzidine, followed by a light counter-
staining with hematoxylin. All findings were evaluated by
a pathologist blinded to the treatment conditions, and
samples were evaluated on the basis of stain intensity and
percentage of reactive cells. Images of representative re-
sults were recorded.Statistical analysis
Cell viability and tumor volume data were statistically
analyzed using unpaired t-test (SPSS, Chicago, IL). P <
0.05 was considered statistically significant.
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Anthocyanins inhibit cell growth in vivo and in vitro
To determine whether anthocyanins exert antitumor ac-
tivity in an in vivo model, we examined their effect on
tumor growth in a Hep3B xenograft model. Anthocyanins
(50 mg · kg−1 · day−1) was administered intraperitoneally
once a day for 20 days, starting 1 week after the initial in-
jection of Hep3B cells. Body weight remained unchanged
in all groups, but tumor growth was significantly reduced
in the anthocyanin-treated group compared with the
control group (Figure 1a). To confirm that anthocyanins
could function as chemopreventive agents, we tested theirFigure 1 Anthocyanins suppress tumor growth in a xenograft model
hepato-carcinoma cells in vitro. (a) Hep3B hepato-carcinoma cells (1 × 10
Balb/C nu/nu mice (n = 5 per group). After 1 week, mice received anthocya
once every 2 days and calculated as described in the Materials and Method
compared with control tumor volume on day 18 or 20. (b) Cells were treat
measured using the MTT assay. *P < 0.05 and ***P < 0.001, compared with
V-FITC, PI or Hoechst 33342 dye (10 μM) and analyzed by flow cytometry oeffect on cell viability. We found that anthocyanins inhib-
ited cell growth in a dose-dependent manner (Figure 1b)
and induced apoptosis, as measured by Annexin V/propi-
dium iodide (PI) staining and Hoechst 33342 staining
(Figure 1c).
In vivo and in vitro regulation of AMPK, GSK3β and
β-catenin, and cell growth effects through inhibition of
AMPK in anthocyanin-treated Hep3B cells
We analyzed the molecular changes between the control
and anthocyanin-treated groups. The phosphorylation
of GSK3β and increased expression of β-catenin wereand decrease cell growth and apoptosis in Hep3B
6 cells/0.1 ml) were injected subcutaneously into the left flanks of
nins s.c. (50 mg/kg/day) for 20 days. Tumor volume was measured
s section. Body weight was measured once each week. *P < 0.05,
ed with anthocyanins (25–400 μg/ml) for 48 h, and cell viability was
control. (c) Anthocyanins-treated cells were stained with Annexin
r fluorescence microscopy.
Park et al. BMC Complementary and Alternative Medicine 2014, 14:109 Page 5 of 9
http://www.biomedcentral.com/1472-6882/14/109significantly suppressed in the anthocyanin-treated group
relative to that in the control group (Figure 2a). Immuno-
histochemical analysis showed that treatment with antho-
cyanins increased the level of p-AMPK compared to the
controls (Figure 2b). In vitro, anthocyanins activated
AMPK (Figure 2c), whereas siRNA-mediated knock-
down of AMPK activity suppressed cancer cell growth
(Figure 2d).
Anthocyanins decrease cell invasion at least in part
through AMPK activation
Tumor invasion is regulated by a multi-step biological
process that involves cell motility, tube-like structure for-
mation, matrix degradation, and cell migration. Previous
reports have revealed that IGF-1 triggers cell migration
and invasion in human endothelial cells and animal
models [19]. Thus, we examined the effects of anthocya-
nins on invasion in IGF-1-treated Hep3B cells. We first
performed a wound-healing experiment in vitro and found
that IGF-1-induced cancer cell motility (as assessed by
wound healing) was suppressed by treatment with
200 μg/ml anthocyanin (Figure 3a). To examine a pos-
sible correlation between anthocyanin-induced AMPK
inhibition and wound healing effect, Hep3B cells were
treated with the AMPK inhibitor Compound C. Com-
pound C increased wound healing in anthocyanin-Figure 2 Anthocyanins regulate GSK3β, β-catenin and AMPK in vivo a
subjected to Western blot analysis for quantification of p-GSK3β and β-cate
immunohistochemical analysis. (c) Cells were treated with anthocyanins (25
blot analysis using antibodies against phospho-AMPK and β-actin (loading
non-specific siRNA (control) for 72 h, treated with anthocyanins for 48 h, an
calculated as a percentage of viable control siRNA-transfected cells.treated Hep3B cells (Figure 3b). Using a Boyden cham-
ber invasion assay, we next examined whether anthocya-
nins decreased the invasiveness of IGF-1-treated Hep3B
cells. As shown in Figure 3b, IGF-1 treatment increased
cell invasiveness, but this effect was reduced by co-
treatment with anthocyanins. During cell migration, which
is an initial step of invasion, the gelatinase activities of
MMP-2 and MMP-9 largely destroy the basal membrane
of the cell. We tested the effects of anthocyanins on
gelatinase activities of MMP-2 to exclude the possibility
that IGF-1 increased MMP-2 expression; however, an-
thocyanins decreased IGF-1-stimulated MMP-2 activity
(Figure 3c). These results suggest that anthocyanins
have potential anti-migrative activity against hepato-
carcinoma cells.
Cluster of differentiation 31 (CD31; also known as plate-
let endothelial cell adhesion molecule 1 or PECAM-1)
is expressed in certain tumors, including epithelioid
sarcoma-like hemangioendothelioma, other vascular tu-
mors, histiocytic malignancies, and plasmacytomas. CD31
can help to evaluate the degree of tumor angiogenesis,
which can indicate a rapidly growing tumor. Because ma-
lignant endothelial cells also commonly retain the antigen,
CD31 immunohistochemistry can also be used to demon-
strate both angiomas and angiosarcomas [20]. We ob-
served reduced CD31 expression in anthocyanin-treatednd AMPK in vitro. (a) Mice were sacrificed and tumor extracts were
nin levels. (b) The level of p-AMPK was also measured by
–400 μg/ml) for 24 h and total proteins were subjected to Western
control). (d) Cells were transiently transfected with AMPK siRNA or
d assessed for viability using the MTT assay. Cell viability was
Figure 3 Anthocyanins inhibit cell invasion by regulating metastasis-related proteins in vivo and in vitro. (a) Hep3B cells were serum
starved for 12 h and grown to confluence on a 6-well plate. Monolayers were wounded with a pipette tip, pretreated with IGF-1 (100 ng/ml) with
or without Compound C for 30 min, and then treated with anthocyanins for 24 h. Images of wound closure were captured under a phase-
contrast microscope after 24 h. (b) Hep3B cells were pretreated with IGF-1 (100 ng/ml) for 30 min, treated with anthocyanins for 24 h, and plated
onto the apical side of Matrigel-coated filters in serum-free medium with or without IGF-1 and/or anthocyanins. Medium containing 2% FBS was
placed in the basolateral chamber to act as a chemo-attractant. After 24 h, cells on the apical side were wiped off using a Q-tip, and cells that
had migrated to the bottom of the filter were stained using crystal violet, and then photographed. (c) Cells were incubated with anthocyanins as
described in (c) and Figure 4c, medium was collected, and MMP-2 activity was measured by zymography. (d) Mice were sacrificed, tumor extracts
were prepared, and immunohistochemical analysis was used to quantify CD31 expression (e) Hep3B cells were transiently transfected with AMPK
siRNA or non-specific siRNA for 72 h, pretreated with IGF-1 (100 ng/ml) for 30 min, treated with anthocyanins (200 μg/ml) for 24 h, and then
subjected to Western blot analysis using antibodies against MMP-9, VEGF, Ang-1, AMPK and β-actin (loading control).
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in vivo (Figure 3d). Anthocyanins did not decrease the
level of VEGF; however, MMP-9 and Ang-1 decreased in
the absence of AMPK (Figure 3e).
Anthocyanin-induced activation of AMPK inhibits
GSK3β/β-catenin-mediated signaling in IGF-1-stimulated
Hep3B cells
Several reports have suggested that IGF-1 increases β-
catenin transcription activity through inhibition of the
destroyed Axin/APC/GSK3β complex and increases cell
proliferation [21]. To elucidate the mechanism of AMPK-
mediated inhibition of cell growth in anthocyanin-treated
cells, we next examined the effects of IGF-1-induced
Hep3B cell growth on the activation of GSK3β/β-catenin
signaling. IGF-1-stimulated cell growth was associated
with enhanced phosphorylation of GSK, an inhibitor, and
increased expression of β-catenin (Figure 4a and b).
We next analyzed these effects in anthocyanin-treated
cells and found that anthocyanins at concentrations
of >100 μg/ml effectively inhibited the IGF-1-stimulated
increase in GSK3β phosphorylation and β-catenin ex-
pression and enhanced the phosphorylation of AMPKin these cells (Figure 4c). To examine the regulatory
mechanism between AMPK and GSK3β, Hep3B cells
were treated with specific inhibitors of AMPK or GSK3β
(Compound C or BIO, respectively) and anthocyanins.
AMPK increased the anthocyanin-induced inhibition of
GSK3β activity compared to anthocyanin treatment alone
(Figure 4d), whereas BIO decreased the anthocyanin-
induced inhibition of GSK3β activity but did not affect the
activation of AMPK (Figure 4e). These results suggest that
GSK3β has an inhibitory effect on AMPK in Hep3B cells
and that the anthocyanin-induced suppression of GSK3β
activity can increase AMPK activity.
Discussion
We detected a significant reduction in the phosphoryl-
ation of GSK3β in anthocyanin-treated hepato-carcinoma
cells, which might result in diminished β-catenin expres-
sion. The dephosphorylation of GSK3β may account for
the destruction of β-catenin, as well as the attenuated
transcription of oncogenes [22]. GSK3β is a significant
cancer control molecule; it controls the degradation of
β-catenin by phosphorylating serine 33/37 of cytosolic β-
catenin, and it may also be involved in crosstalk with the
Figure 4 Anthocyanins inhibit GSK3β and β-catenin in an AMPK-dependent manner. (a) Hep3B cells were serum-starved for 12 h, treated
with IGF-1 (50–200 ng/ml) for 24 or 48 h, and then stained with trypan blue. Viable cells were counted under a hemacytometer. (b) Hep3B cells
were serum-starved for 12 h, treated with IGF-1 (50–200 ng/ml) for 24 h, and then subjected to Western blot analysis using antibodies against
p-GSK3β, β-catenin and β-actin (loading control). (c) Hep3B cells were serum-starved for 12 h, pretreated with IGF-1 (100 ng/ml) for 30 min, and
treated with anthocyanins (50–100 μM) for 24 h. Total proteins were subjected to Western blot analysis using antibodies against p-GSK3β, GSK3β,
p-AMPK, AMPK, β-catenin and β-actin (loading control). (d) Hep3B cells were serum-starved (for 12 h), pretreated with IGF-1 (100 ng/ml) and
10 μM of Compound C for 30 min, and then treated with anthocyanins for 24 h. Western blot analysis was used to compare protein levels.
(e) Hep3B cells were serum-starved for 12 h, pretreated with IGF-1 (100 ng/ml) and 2 μM of BIO for 30 min, and treated with anthocyanins for
24 h. Western blot analysis was used to compare protein levels.
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cell proliferation and metastasis4–7. Inactivation (i.e.,
phosphorylation) of GSK3β can inhibit the nuclear
translocation of β-catenin, decreasing the transcription
responsible for cell proliferation [23]. Increased expres-
sion of β-catenin has been observed in several cancer
types, including hepato-carcinoma [24].A large body of evidence suggests that AMPK activa-
tion is associated with the inhibition of cancer cell pro-
liferation and metastasis [25]. Here, we report that
anthocyanins activate AMPK expression in vivo and
in vitro, dramatically inhibit in vitro hepato-carcinoma
cell invasion, and down-regulate metastasis-related sig-
naling molecules such as VEGF, MMP-9, and Ang-1.
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tion and invasion by inhibiting MMP-2 in vitro and
CD31 (a panendothelial marker) in vivo. Several signal-
ing pathways downstream of AMPK have been shown
to control cancer cell proliferation and metastasis, in-
cluding the AMPK/MAPK, JNK/STAT3, and AMPK/
p53 pathways [25-28].
Here, we used AMPK and GSK3β inhibitors to investi-
gate whether the ability of AMPK to regulate the GSK3β/
β-catenin pathway is required for anthocyanins to exert
their anti-proliferative and anti-metastatic functions. When
AMPK was inhibited by Compound C, anthocyanin treat-
ment failed to decrease p-GSK3β, indicating that AMPK
activation is required for anthocyanins to regulate p-
GSK3β. In contrast, BIO-mediated inhibition of GSK3β
stimulated β-catenin but did not significantly alter
AMPK activation. Taken together, our findings suggest
that AMPK-mediated regulation of GSK3β is respon-
sible for the anthocyanin-induced decrease in the prolif-
eration and metastatic potential of hepato-carcinoma
cells.
Conclusion
This study provides evidence that the interplay between
GSK3β and β-catenin, regulated by AMPK signaling,
may contribute to cancer cell proliferation and metasta-
sis. Given that the down-regulation of GSK3β/β-catenin
activity appears to decrease the tumorigenic potential of
hepato-carcinoma cells, molecules that are involved in
the AMPK-mediated regulation of GSK3β, such as antho-
cyanins, could serve as potential therapeutic targets for
the suppression of cancer progression and metastasis.
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